# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
1 | 10-04-2025 | 06-30-2025 | 10-Q | |
2 | 05-31-2025 | 03-31-2025 | 10-Q |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Liminatus Pharma, Inc. (NASDAQ:LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted ca...
Liminatus Pharma, Inc. (NASDAQ:LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted ca...